These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38155289)

  • 1. An observational multi-center study on type 2 diabetes treatment prescribing pattern and patient adherence to treatment.
    Butt MD; Ong SC; Rafiq A; Malik T; Sajjad A; Batool N; Chughtai AUH; Wahab MU; Abdullah M; Babar ZU
    Sci Rep; 2023 Dec; 13(1):23037. PubMed ID: 38155289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study.
    Manski-Nankervis JA; Thuraisingam S; Sluggett JK; Kilov G; Furler J; O'Neal D; Jenkins A
    BMC Fam Pract; 2019 Feb; 20(1):29. PubMed ID: 30777033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.
    Yusuff KB; Obe O; Joseph BY
    Pharm World Sci; 2008 Dec; 30(6):876-83. PubMed ID: 18784982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of adherence to anti-diabetic medications among type 2 diabetic patients in a Sudanese outpatient clinic.
    Mirghani HO
    Pan Afr Med J; 2019; 34():34. PubMed ID: 31762902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral diabetes medications on glycated haemoglobin (HbA1c) in Asians in primary care: a retrospective cohort real-world data study.
    Fang HSA; Gao Q; Tan WY; Lee ML; Hsu W; Tan NC
    BMC Med; 2022 Jan; 20(1):22. PubMed ID: 35078484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
    Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F;
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.
    Alvarez Guisasola F; Tofé Povedano S; Krishnarajah G; Lyu R; Mavros P; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():25-32. PubMed ID: 18435671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
    Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
    JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing pattern of anti-diabetic drugs and adherence to the American Diabetes Association's (ADA) 2021 treatment guidelines among patients of type 2 diabetes mellitus: A cross-sectional study.
    Tiwari K; Bisht M; Kant R; Handu SS
    J Family Med Prim Care; 2022 Oct; 11(10):6159-6164. PubMed ID: 36618206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Diabetes-related Knowledge and Medication Adherence: Results From Cross-sectional Analysis.
    Nazir SU; Hassali MA; Saleem F; Bashir S; Aljadhey H
    Altern Ther Health Med; 2016 Nov; 22(6):8-13. PubMed ID: 27866175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.
    Ayele AA; Tegegn HG; Ayele TA; Ayalew MB
    BMJ Open Diabetes Res Care; 2019; 7(1):e000685. PubMed ID: 31321061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42).
    Fujihara K; Igarashi R; Matsunaga S; Matsubayashi Y; Yamada T; Yokoyama H; Tanaka S; Shimano H; Maegawa H; Yamazaki K; Kawai K; Sone H
    Medicine (Baltimore); 2017 Feb; 96(7):e6122. PubMed ID: 28207538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents.
    Vinik AI; Cincotta AH; Scranton RE; Bohannon N; Ezrokhi M; Gaziano JM
    Endocr Pract; 2012; 18(6):931-43. PubMed ID: 23186965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.
    Vichayanrat A; Matawaran BJ; Wibudi A; Ferdous HS; Aamir AH; Aggarwal SK; Bajpai S
    J Diabetes; 2013 Sep; 5(3):309-18. PubMed ID: 23462227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance.
    Benford M; Milligan G; Pike J; Anderson P; Piercy J; Fermer S
    Adv Ther; 2012 Jan; 29(1):26-40. PubMed ID: 22246944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model: A retrospective observational study.
    Lee KA; Jin HY; Kim YJ; Kim SS; Cho EH; Park TS
    Medicine (Baltimore); 2022 Feb; 101(8):e28823. PubMed ID: 35212277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
    Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus.
    Mahmoud F; Mullen A; Sainsbury C; Rushworth GF; Yasin H; Abutheraa N; Mueller T; Kurdi A
    Eur J Clin Invest; 2023 Aug; 53(8):e13997. PubMed ID: 37002856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.